|
|
|
| Webinar: Fixing the Monitoring Model: How a Flexible Resource Supports Trial Success | As clinical trials grow increasingly complex, traditional monitoring models are showing their cracks. Overextended CRAs, inconsistent site engagement, and reactive oversight can lead to delays, data quality issues, and strained site relationships. Join clinical operations experts for a candid conversation about what's not working in today’s trial monitoring—and what could. |
|
|
|
|
On this Business of Biotech episode, Dr. Srinivas Rao, co-founder and CEO at atai Life Sciences, explains how his engineering background led him to the development of psychedelic compounds for treating depression, anxiety, and other mental health disorders. Internal drug development efforts at atai are focused on short-duration psychedelics that can work within existing healthcare infrastructure, with the potential to transform the treatment of mental health disorders. |
|
|
|
| Key Criteria For Choosing The Right Phase 1 CRO | What steps can you take to select the best CRO partner for your Phase 1 clinical trial? Evaluate several factors, such as therapeutic area expertise, experience with trial complexity, and cost transparency. |
|
|
|
| The Streetlight Effect | Examine the shortcomings of existing clinical trial finders, particularly regarding the accessibility of eligibility criteria for patients seeking treatment options. |
|
|
|
|
|
|
